Hanmi Pharm Co Ltd (128940) — Capital Reinvestment Ratio
Hanmi Pharm Co Ltd (128940) has a Capital Reinvestment Ratio of 0.38x as of September 2025, meaning it reinvests 0% of its operating cash flow (₩42.02 Billion) in capital expenditures (₩15.95 Billion). Check Hanmi Pharm Co Ltd tangible equity quality to evaluate the tangible quality of the company's equity base.
Capital Reinvestment Ratio
Operating Cash Flow
Capital Expenditures
Data as of
Hanmi Pharm Co Ltd Capital Reinvestment Ratio (2010–2024)
This chart tracks Hanmi Pharm Co Ltd's Capital Reinvestment Ratio across 13 annual periods. For the full cash flow conversion analysis, see 128940 cash generation efficiency.
Annual Capital Reinvestment Ratio for Hanmi Pharm Co Ltd (2010–2024)
Year-by-year Capital Reinvestment Ratio for Hanmi Pharm Co Ltd from 2010 to 2024. See 128940 free cash flow to operating cash ratio to measure how efficiently the company converts operating cash flow to free cash.
| Year | Reinvestment Ratio | Operating CF (KRW) | Capital Expenditures | YoY Change |
|---|---|---|---|---|
| 2024 | 0.32x | ₩193.49 Billion | ₩62.55 Billion | ▲ +60.1% |
| 2023 | 0.20x | ₩216.54 Billion | ₩43.74 Billion | ▲ +7.9% |
| 2022 | 0.19x | ₩162.27 Billion | ₩30.38 Billion | ▲ +89.5% |
| 2021 | 0.10x | ₩201.92 Billion | ₩19.95 Billion | ▼ -64.2% |
| 2020 | 0.28x | ₩151.53 Billion | ₩41.82 Billion | ▼ -97.9% |
| 2019 | 13.35x | ₩12.45 Billion | ₩166.13 Billion | ▲ +90.3% |
| 2018 | 7.02x | ₩25.98 Billion | ₩182.27 Billion | ▲ +1192.8% |
| 2016 | 0.54x | ₩412.97 Billion | ₩224.09 Billion | ▼ -54.4% |
| 2015 | 1.19x | ₩101.71 Billion | ₩121.07 Billion | ▲ +285.2% |
| 2013 | 0.31x | ₩85.99 Billion | ₩26.57 Billion | ▲ +40.9% |
| 2012 | 0.22x | ₩63.27 Billion | ₩13.87 Billion | ▼ -31.3% |
| 2011 | 0.32x | ₩61.30 Billion | ₩19.56 Billion | ▼ -70.5% |
| 2010 | 1.08x | ₩18.94 Billion | ₩20.46 Billion | — |